News & Updates
Filter by Specialty:
Is it safe to take olmesartan in combination therapy for advanced hypertension?
Use of olmesartan in combination practice is safe and results in similar cardiovascular composite outcomes, including myocardial infarction (MI), when compared with active comparators in hypertensive patients who need more than two antihypertensive medications, reports a study.
Is it safe to take olmesartan in combination therapy for advanced hypertension?
14 Sep 2023
Bulevirtide boasts high barrier to resistance for chronic hepatitis delta
A recent study has found no amino acid substitutions associated with reduced sensitivity to bulevirtide (BLV) monotherapy, a hepatitis D/B virus (HDV/HBV) entry inhibitor, at baseline or week 24 in patients with virologic breakthrough after BLV treatment.
Bulevirtide boasts high barrier to resistance for chronic hepatitis delta
13 Sep 2023
Noninvasive MRE accurately stages liver fibrosis in NAFLD
Magnetic resonance elastography demonstrates high accuracy in the noninvasive staging of liver fibrosis in patients with nonalcoholic fatty liver disease (NAFLD), reports a study.
Noninvasive MRE accurately stages liver fibrosis in NAFLD
13 Sep 2023
Wine intake inversely tied to CV outcomes
A systematic review and meta-analysis showed an inverse relationship between wine consumption and the risks of cardiovascular (CV) mortality, CV disease (CVD), and coronary heart disease (CHD).
Wine intake inversely tied to CV outcomes
13 Sep 2023
SHBG levels inversely linked to hypertension in middle-aged adults
Levels of sex hormone-binding globulin (SHBG) show an inverse relationship with the development of hypertension and change in blood pressure (BP) levels, independent of major risk factors, according to a community-based study.